Hypera S.A. (HYPE3.SA)
BRL 16.8
(-5.46%)
BRL 16.8
(-5.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.99 Billion BRL | 1.89% |
| 2022 | 4.76 Billion BRL | 25.21% |
| 2021 | 3.8 Billion BRL | 44.64% |
| 2020 | 2.62 Billion BRL | 26.06% |
| 2019 | 2.08 Billion BRL | -21.75% |
| 2018 | 2.66 Billion BRL | -1.71% |
| 2017 | 2.71 Billion BRL | 11.05% |
| 2016 | 2.44 Billion BRL | 10.49% |
| 2015 | 2.21 Billion BRL | -25.88% |
| 2014 | 2.98 Billion BRL | 8.48% |
| 2013 | 2.74 Billion BRL | 14.1% |
| 2012 | 2.4 Billion BRL | 20.21% |
| 2011 | 2 Billion BRL | 10.94% |
| 2010 | 1.8 Billion BRL | 52.78% |
| 2009 | 1.18 Billion BRL | 48.15% |
| 2008 | 798.05 Million BRL | 29.85% |
| 2007 | 614.6 Million BRL | 219.34% |
| 2006 | 192.45 Million BRL | -10.44% |
| 2005 | 214.9 Million BRL | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.07 Billion BRL | -3.08% |
| 2024 Q2 | 1.29 Billion BRL | 24.29% |
| 2023 Q3 | 1.35 Billion BRL | -3.93% |
| 2023 Q1 | 1.08 Billion BRL | -17.84% |
| 2023 FY | 4.85 Billion BRL | 1.89% |
| 2023 Q2 | 1.4 Billion BRL | 29.75% |
| 2023 Q4 | 1.1 Billion BRL | -18.23% |
| 2022 Q1 | 939.19 Million BRL | -7.82% |
| 2022 Q2 | 1.2 Billion BRL | 28.62% |
| 2022 Q3 | 1.29 Billion BRL | 6.98% |
| 2022 Q4 | 1.32 Billion BRL | 2.29% |
| 2022 FY | 4.76 Billion BRL | 25.21% |
| 2021 Q3 | 1.04 Billion BRL | 5.65% |
| 2021 FY | 3.8 Billion BRL | 44.64% |
| 2021 Q1 | 752.79 Million BRL | 7.59% |
| 2021 Q2 | 987.67 Million BRL | 31.2% |
| 2021 Q4 | 1.01 Billion BRL | -2.36% |
| 2020 FY | 2.62 Billion BRL | 26.06% |
| 2020 Q2 | 690.25 Million BRL | 27.1% |
| 2020 Q1 | 543.05 Million BRL | -1.87% |
| 2020 Q4 | 699.68 Million BRL | 0.49% |
| 2020 Q3 | 696.27 Million BRL | 0.87% |
| 2019 Q4 | 553.39 Million BRL | -18.77% |
| 2019 Q1 | 185.86 Million BRL | -70.8% |
| 2019 Q3 | 681.3 Million BRL | 2.43% |
| 2019 Q2 | 665.12 Million BRL | 257.85% |
| 2019 FY | 2.08 Billion BRL | -21.75% |
| 2018 Q3 | 670.54 Million BRL | 0.31% |
| 2018 Q1 | 689.68 Million BRL | 3.12% |
| 2018 FY | 2.66 Billion BRL | -1.71% |
| 2018 Q4 | 636.59 Million BRL | -5.06% |
| 2018 Q2 | 668.45 Million BRL | -3.08% |
| 2017 Q3 | 712.57 Million BRL | 11.79% |
| 2017 Q2 | 637.39 Million BRL | -8.02% |
| 2017 Q1 | 692.94 Million BRL | 12.66% |
| 2017 FY | 2.71 Billion BRL | 11.05% |
| 2017 Q4 | 668.79 Million BRL | -6.14% |
| 2016 Q3 | 608.68 Million BRL | -0.47% |
| 2016 FY | 2.44 Billion BRL | 10.49% |
| 2016 Q4 | 615.1 Million BRL | 1.05% |
| 2016 Q2 | 611.55 Million BRL | 0.81% |
| 2016 Q1 | 606.61 Million BRL | 658.06% |
| 2015 Q2 | 782.33 Million BRL | 6.44% |
| 2015 Q3 | 801.48 Million BRL | 2.45% |
| 2015 Q4 | -108.7 Million BRL | -113.56% |
| 2015 FY | 2.21 Billion BRL | -25.88% |
| 2015 Q1 | 735.02 Million BRL | -7.72% |
| 2014 Q1 | 681.06 Million BRL | -4.96% |
| 2014 Q4 | 796.51 Million BRL | 4.56% |
| 2014 Q3 | 761.74 Million BRL | 2.57% |
| 2014 FY | 2.98 Billion BRL | 8.48% |
| 2014 Q2 | 742.67 Million BRL | 9.05% |
| 2013 Q3 | 715.76 Million BRL | 1.69% |
| 2013 Q2 | 703.9 Million BRL | 14.9% |
| 2013 Q1 | 612.59 Million BRL | -2.95% |
| 2013 FY | 2.74 Billion BRL | 14.1% |
| 2013 Q4 | 716.58 Million BRL | 0.11% |
| 2012 Q4 | 631.2 Million BRL | 1.96% |
| 2012 Q1 | 557.56 Million BRL | 33.82% |
| 2012 Q2 | 601.24 Million BRL | 7.83% |
| 2012 Q3 | 619.09 Million BRL | 2.97% |
| 2012 FY | 2.4 Billion BRL | 20.21% |
| 2011 Q4 | 416.65 Million BRL | -15.9% |
| 2011 Q1 | 525.42 Million BRL | 8.4% |
| 2011 FY | 2 Billion BRL | 10.94% |
| 2011 Q2 | 566.53 Million BRL | 7.82% |
| 2011 Q3 | 495.43 Million BRL | -12.55% |
| 2010 FY | 1.8 Billion BRL | 52.78% |
| 2010 Q3 | 508.49 Million BRL | 18.07% |
| 2010 Q2 | 430.67 Million BRL | 15.04% |
| 2010 Q4 | 484.72 Million BRL | -4.67% |
| 2010 Q1 | 374.38 Million BRL | -8.06% |
| 2009 Q2 | 252.14 Million BRL | 19.9% |
| 2009 Q1 | 210.29 Million BRL | 0.0% |
| 2009 FY | 1.18 Billion BRL | 48.15% |
| 2009 Q4 | 407.19 Million BRL | 34.82% |
| 2009 Q3 | 302.02 Million BRL | 19.78% |
| 2008 FY | 798.05 Million BRL | 29.85% |
| 2007 FY | 614.6 Million BRL | 219.34% |
| 2006 FY | 192.45 Million BRL | -10.44% |
| 2005 FY | 214.9 Million BRL | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Blau Farmacêutica S.A. | 464.3 Million BRL | -975.926% |